Tot nu toe werd gedacht dat diabetes type 2 (T2DM) een ongeneeslijke aandoening was. Maar nieuw onderzoek laat zien dat deze ziekte, zelfs bij patiënten die al insuline gebruiken, te genezen is. Hier stellen we een behandeling voor die uit een combinatie bestaat van een voedingsinterventie, aanvulling van voedingstekorten en fytotherapie, bij uitstek het werkterrein van een natuur- of voedingsgeneeskundig therapeut. Therapeuten kunnen hierdoor een sleutelpositie innemen bij het terugdringen van deze ernstige ziekte.
Beste bezoeker, u heeft geen toegang.
Enkel (web)abonnees hebben toegang tot tijdschriftartikelen. Het webabonnement is nog in de maak.
U kunt zich wel alvast (gratis) registreren en tal van andere webartikelen raadplegen!
Abonnementsactie
Voorop lopen in je vak? Voedingsgeneeskunde helpt je daarbij. Met artikelen over toonaangevende personen, belangrijke ontwikkelingen en relevante informatie praten we je bij over wat er speelt in de nutritionele geneeskunde en alles wat daarmee te maken heeft. Als je nu inschrijft voor een abonnement, krijg je het eerste nummer gratis.
Auteur
Trefwoorden:
Figuren
Verschenen in
Referenties
Diabetes FondsL Diabetes in cijfers [Article]
Duncan BB1, Schmidt MI, Pankow JS, Ballantyne CM, Couper D, Vigo A, Hoogeveen R, Folsom AR, Heiss G; Atherosclerosis Risk in Communities Study Diabetes. 2003 Jul;52(7):1799-805.Low-grade systemic inflammation and the development of type 2 diabetes: the atherosclerosis risk in communities study [Article]
Steckhan N, Hohmann CD, Kessler C, Dobos G, Michalsen A, Cramer H.Nutrition. 2016 Mar;32(3):338-48. doi: 10.1016/j.nut.2015.09.010. Effects of different dietary approaches on inflammatory markers in patients with metabolic syndrome: A systematic review and meta-analysis [Abstract]
RIVM: Nederland de Maat Genomen, 2009- 2010 [Article]
Ligthart S, van Herpt TT, Leening MJ, Kavousi M, Hofman A, Stricker BH, van Hoek M, Sijbrands EJ, Franco OH, Dehghan A. Lancet Diabetes Endocrinol. 2016 Jan;4(1):44-51. doi: 10.1016/S2213-8587(15)00362-9. Lifetime risk of developing impaired glucose metabolism and eventual progression from prediabetes to type 2 diabetes: a prospective cohort study [Article]
Buchwald H1, Avidor Y, Braunwald E, Jensen MD, Pories W, Fahrbach K, Schoelles K. JAMA. 2004 Oct 13;292(14):1724-37. Bariatric surgery: a systematic review and meta-analysis [Abstract]
Taylor R Diabetes Care. 2013 Apr;36(4):1047-55. Type 2 diabetes: etiology and reversibility [Article]
Steven S, Lim EL, Taylor R. Diabet Med. 2013 Apr;30(4):e135-8. doi: 10.1111/dme.12116. Population response to information on reversibility of Type 2 diabetes [Abstract]
Dibaba DT1, Xun P1, He K1. Eur J Clin Nutr. 2014 Apr;68(4):510-6. doi: 10.1038/ejcn.2014.7. Dietary magnesium intake is inversely associated with serum C-reactive protein levels: meta-analysis and systematic review [Article]
Gibb RD, McRorie JW Jr, Russell DA, Hasselblad V, D'Alessio DA. Am J Clin Nutr. 2015 Dec;102(6):1604-14. doi: 10.3945/ajcn.115.106989. Psyllium fiber improves glycemic control proportional to loss of glycemic control: a meta-analysis of data in euglycemic subjects, patients at risk of type 2 diabetes mellitus, and patients being treated for type 2 diabetes mellitus [Article]
Del Prato S. Presse Med. 1992 Sep 9;21(28):1312-7. Hyperinsulinism. Causes and mechanisms [Abstract]
Wallace TM, Levy JC, Matthews DR Diabetes Care. 2004 Jun;27(6):1487-95. Use and abuse of HOMA modeling [Article]
NHG-Standaard Het PreventieConsult module Cardiometabool Risico [Article]
Connelly MA, Gruppen EG2, Otvos JD1, Dullaart RP3 Clin Chim Acta. 2016 Aug 1;459:177-86. doi: 10.1016/j.cca.2016.06.012. Inflammatory glycoproteins in cardiometabolic disorders, autoimmune diseases and cancer [Article]
Gruchała-Niedoszytko M, Małgorzewicz S, Niedoszytko M, Gnacińska M, Jassem E. Adv Med Sci. 2013;58(1):15-21. doi: 10.2478/v10039-012-0082-y. The influence of obesity on inflammation and clinical symptoms in asthma [Abstract]
Dias JA1, Fredrikson GN2, Ericson U3, Gullberg B1, Hedblad B4, Engström G4, Borgquist S5, Nilsson J2, Wirfält E1. PLoS One. 2016 Jul 8;11(7):e0158959. doi: 10.1371/journal.pone.0158959. eCollection 2016. Low-Grade Inflammation, Oxidative Stress and Risk of Invasive Post-Menopausal Breast Cancer - A Nested Case-Control Study from the Malmö Diet and Cancer Cohort [Article]
Kaptoge S, Seshasai SR, Gao P, Freitag DF, Butterworth AS, Borglykke A, Di Angelantonio E, Gudnason V, Rumley A, Lowe GD, Jørgensen T, Danesh J. Eur Heart J. 2014 Mar;35(9):578-89. doi: 10.1093/eurheartj/eht367. Inflammatory cytokines and risk of coronary heart disease: new prospective study and updated meta-analysis [Article]
Orlowsky EW, Kraus VB2. J Rheumatol. 2015 Mar;42(3):363-71. doi: 10.3899/jrheum.140382. The role of innate immunity in osteoarthritis: when our first line of defense goes on the offensive [Article]
Glaros TG1, Chang S, Gilliam EA, Maitra U, Deng H, Li L Front Biosci (Schol Ed). 2013 Jan 1;5:754-65. Causes and consequences of low grade endotoxemia and inflammatory diseases [Abstract]
Escobar-Morreale HF, Luque-Ramírez M, González F. Fertil Steril. 2011 Mar 1;95(3):1048-58.e1-2. doi: 10.1016/j.fertnstert.2010.11.036. Circulating inflammatory markers in polycystic ovary syndrome: a systematic review and metaanalysis [Article]
De Felice FG1, Ferreira ST2. Diabetes. 2014 Jul;63(7):2262-72. doi: 10.2337/db13-1954. Inflammation, defective insulin signaling, and mitochondrial dysfunction as common molecular denominators connecting type 2 diabetes to Alzheimer disease [Article]
Mottillo S, Filion KB, Genest J, Joseph L, Pilote L, Poirier P, Rinfret S, Schiffrin EL, Eisenberg MJ. J Am Coll Cardiol. 2010 Sep 28;56(14):1113-32. doi: 10.1016/j.jacc.2010.05.034. The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis [Article]
Thomas G, Sehgal AR, Kashyap SR, Srinivas TR, Kirwan JP, Navaneethan SD. Clin J Am Soc Nephrol. 2011 Oct;6(10):2364-73. doi: 10.2215/CJN.02180311. Metabolic syndrome and kidney disease: a systematic review and meta-analysis [Article]
Gacci M, Corona G, Vignozzi L, Salvi M, Serni S, De Nunzio C, Tubaro A, Oelke M, Carini M, Maggi M. BJU Int. 2015 Jan;115(1):24-31. doi: 10.1111/bju.12728. Metabolic syndrome and benign prostatic enlargement: a systematic review and meta-analysis [Article]
Esposito K, Chiodini P, Capuano A, Bellastella G, Maiorino MI, Giugliano D. Endocrine. 2014 Feb;45(1):28-36. doi: 10.1007/s12020-013-9973-3. Metabolic syndrome and endometrial cancer: a meta-analysis [Article]
Esposito K, Chiodini P, Colao A, Lenzi A, Giugliano D. Diabetes Care. 2012 Nov;35(11):2402-11. doi: 10.2337/dc12-0336.Metabolic syndrome and risk of cancer: a systematic review and meta-analysis [Article]
Rosato V, Tavani A, Bosetti C, Pelucchi C, Talamini R, Polesel J, Serraino D, Negri E, La Vecchia C. Metabolism. 2011 Oct;60(10):1372-8. doi: 10.1016/j.metabol.2011.03.005. Metabolic syndrome and pancreatic cancer risk: a case-control study in Italy and meta-analysis [Abstract]
Esposito K, Chiodini P, Capuano A, Bellastella G, Maiorino MI, Rafaniello C, Giugliano D. Menopause. 2013 Dec;20(12):1301-9. doi: 10.1097/GME.0b013e31828ce95d. Metabolic syndrome and postmenopausal breast cancer: systematic review and meta-analysis [Abstract]
Savva SC, Lamnisos D, Kafatos AG. Diabetes Metab Syndr Obes. 2013 Oct 24;6:403-19. doi: 10.2147/DMSO.S34220. Predicting cardiometabolic risk: waist-to-height ratio or BMI. A meta-analysis [Article]
Bonci E, Chiesa C, Versacci P, Anania C, Silvestri L, Pacifico L. Biomed Res Int. 2015;2015:213737. doi: 10.1155/2015/213737. Association of Nonalcoholic Fatty Liver Disease with Subclinical Cardiovascular Changes: A Systematic Review and Meta-Analysis [Article]
Aller R1, Izaola O, Gómez S, Tafur C, González G, Berroa E, Mora N, González JM, de Luis DA. Eur Rev Med Pharmacol Sci. 2015 Aug;19(16):3118-24. Effect of silymarin plus vitamin E in patients with non-alcoholic fatty liver disease. A randomized clinical pilot study [Article]
Bonci E1, Chiesa C2, Versacci P3, Anania C3, Silvestri L3, Pacifico L3. Biomed Res Int. 2015;2015:213737. doi: 10.1155/2015/213737. Association of Nonalcoholic Fatty Liver Disease with Subclinical Cardiovascular Changes: A Systematic Review and Meta-Analysis [Article]
Valensi P1 Presse Med. 1992 Sep 9;21(28):1307-11. Pathogenic role of hyperinsulinism in macroangiopathy. Epidemiological data [Abstract]
